Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.21 which represents a slight increase of $1.36 or 4.41% from the prior close of $30.85. The stock opened at $31.29 and ...

Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity Group from $28.00 to $38.00 in a report released on ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares were up 6.6% during trading on Tuesday after Canaccord Genuity Group raised their price target on the stock from $28.00 to $38.00.

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that ...

Canaccord raised the firm’s price target on Hims & Hers to $38 from $28 and keeps a Buy rating on the shares. The stock rallied 70% in ...

The Washington Post: This Year, Be Thankful For AI In Medicine Artificial intelligence is revolutionizing medicine, making health care more accurate and less expensive for everyone. (11/27) ...

On Friday, Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $32.15 which represents a slight increase of $1.81 or 5.97% from the prior close of $30.34. The stock opened at ...

Everyone has a right to their own opinions. But we must ensure the antisemitic views of individuals are known to their ...

The small cap stocks had a good November with the Russell 2000 index this week hitting a new 52-week peak — higher than the ...

Hims & Hers achieved a 44% YoY increase in Q3 2024, surpassing 2 million active users. Find out what positions HIMS as a key ...

The bitter irony is that Republican policies in states with high obesity rates only exacerbate the gaps in health outcomes.